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AbstractCoronary vessel development is a crucial part of heart developmentrequiring the interplay of the epicardial, myocardial and endocardial layers of theheart for proper formation. Coronary vascularization is regulated by a host oftranscription factors further regulated by chromatin remodeling enzymes, includingHistone Deacetylases (HDACs). To investigate the functions of HDACs in coronaryvascular development, we have deleted Hdac3 in endocardial cells using Cre LoxPtechnology. Endocardial cell-­‐specific deletion of Hdac3 results in aberrant coronaryvessel formation and complete postnatal lethality. We have thus shown that Hdac3is a critical regulator of the coronary vascular development pathway.
vii
Table of ContentsTitle Page……………………………………………………………………………………………………………...iSignature Page……………………………………………………………………………………………………..iiDedication…………………………………………………………………………………………………………..iiiAcknowledgements……………………………………………………………………………………………..ivAbstract………………………………………………………………………………………………………………viTable of Contents……………………………………………………………………………………………….viiList of Figures and Tables…………………………………………………………………………………..viii
CHAPTER I: Introduction…………………………………………………………………………………1Vascular Development of the murine embryo………………………………………………………..2Murine coronary vessel development……………………………………………………………………7Chromatin dynamics…………………………………………………………………………………………..12Histone Deacetylases………………………………………………………………………………………….17
CHAPTER II: Endothelial specific deletion of HDAC3 in mice results in aberrant
coronary vasculature and postnatal death.……………….…………………………………..24Rationale and Significance………………………………………………………………………………….25Results………………………………………………………………………………………………………………26Methods…………………………………………………………………………………………………………….26Discussion………………………………………………………………………………………………………….28Figures………………………………………………………………………………………………………………31
REFFERENCES……………………………………………………………………....……………………….39
viii
List of Tables and Figures
CHAPTER II: Endothelial specific deletion of HDAC3 in mice results in aberrant
coronary vasculature and postnatal deathTable 1: Genotypes of mice of crosses between Hdac3F/+; Cdh5 Cre and Hdac3F/+mice…………………………………………………………………………………………………..………………31Figure 1: Gross observation and histological analysis of E14.5 embryos revealnormal peripheral and coronary vessel development…………………………………………..32Figure 2: Gross observation and histological analysis of E16.5 embryos revealnormal peripheral and coronary vessel development…………………………………………..33Figure 3: Gross observation and histological analysis of P0 hearts reveal coronaryvessel abnormalities…………………………………………………………………………………………..34Figure 4: Gross observation and histological analysis of P0 hearts reveal coronaryvessel abnormalities…………………………………………………………………………………………..35Figure 5: Gross observation and histological analysis of P0 hearts reveal coronaryvessel abnormalities…………………………………………………………………………………………..36Figure 6: Mitral and Tricuspid valves of HDAC3EKO mice display normaldevelopment……………………………………………………………………………………………………...37Figure 7: Occasional Ventricular septal defects observed in Hdac3EKOmice………………………………………………………………………………………………...………..............38
1
Chapter I Introduction
2
Vascular development of the murine embryoVascular development begins with the specification of hemangioblasts, theprecursors of both angioblasts and hematopoetic cells, frommesodermal tissues(Choi et al. 1998). Hemangioblasts coalesce to form the preliminary vascular plexusthat will give rise to the major blood vessels of the embryo (Pardanaud andDieterlen-­‐Lièvre 1993). The vascular plexus forms as early as embryonic day 7.5(e7.5) as indicated by the formation of the bilateral dorsal aorta. Developmentcontinues with the sinus venosus, the conotruncus, and the primitive heart tubeforming by embryonic day e8.5 (Baldwin 1996). This has led to the belief that theheart forms initially as a part of this initial vascular plexus formation and becomessurrounded by a myocardial mantle separated by a layer of extracellular matrixknown as the cardiac jelly (Baldwin 1996). From the preliminary vascular plexus,the vascular system of the developing embryo expands throughout the wholeembryo. Vascularization of the murine embryo continues with formation of bloodislands, consist of a ring of angioblasts that will differentiate into endothelial cellssurrounding a core of hematopoeitic cells (Risau and Flamme 1995). Angioblastscan come together to form lumen-­‐less chords of cells in response to environmentalcues as demonstrated by experiments with chick quail chimeras (Klessinger andChrist 1996). These chords then rearrange themselves to form a vessel lumen byeither altering intracellular distance or by arranging intracellular vacuoles togenerate space between cells in a process known as tubulogenesis (Iruela-­‐Arispeand Davis 2009). The overall formation of vessels from cellular precursors is termedvasculogenesis. Endodermal and ectodermal tissue layers that lack the ability to
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produce hemangioblast progenitor cells are largely vascularized by angiogenesis(Risau and Flamme 1995). It is very common in vascular development for vesselsgenerated by vasculogenic processes to give rise to other vessels throughangiogenesis (Siekmann and Lawson 2007).Angiogenesis is the extension of the vascular network from a pre-­‐establishedplexus. Endothelial cells making up the lining of the forming blood vessels respondto angiogenic signaling factors including VEGF and Angiopoietin 2 (Ang2) toproduce sprouts controlled by Notch and Delta-­‐like ligand 4 (Dll4) signalingcascades (Phng and Gerhardt 2009; Siekmann and Lawson 2007). A “tip” celldesignated by expression of Dll4 triggers Notch expression in neighboring cells,inhibiting migration and altering cellular responses to VEGF (Benedito andHellström 2013). When exposed to VEGF, tip cells express philopedia and migratetowards the VEGF signal. Neighboring “stalk” cells divide in response to VEGFsignaling, elongating the sprout as it migrates towards the source of VEGF (Phng andGerhardt 2009). In addition, stalk cells generate the vessel lumen and expressadhesion molecules critical to forming a stable, functioning vessel (Phng andGerhardt 2009). Sprouting vessels meet through anastomosis, forming newconnections between major vessels (Phng and Gerhardt 2009). Tie-­‐2-­‐Angiopoietin 2signaling also stimulates an angiogenic response, affecting mostly migration andtubulogenesis (Mochizuki et al. 2002). Some studies suggest that angiogenesis andvasculogenesis can occur simultaneously, with angiogenic sprouts connectingnetworks of formerly avascular vessels to systemic circulation. Once formed, thesevessels are stabilized by the association of advential layers of cells and layers of
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extracellular matrix that form around the endothelial inner lining of the bloodvessels (Orlidge and D’Amore 1987; Gaengel et al. 2009).Advential cells include mural cells and connective tissue cells that surroundmature blood vessels. Mural cells consist of either pericytes or smooth muscle cellsthat are a part of the advential layer of capillaries, arteries and veins respectively.These cells originate frommesodermal tissues and migrate to vascular endothelialcells in response to a chemotactic signaling gradient including signaling moleculessuch as PDGFβ expressed by vascular endothelial cells (Gaengel et al. 2009). Muralcell interactions with endothelial cells down regulate proliferative and migratoryendothelial signaling pathways while up regulating endothelial cell differentiationand survival signaling pathways (Gaengel et al. 2009). In addition, Tie-­‐2 signalingpromotes mural cell adhesion to vascular endothelial cells (Gaengel et al. 2009).Notch signaling pathways down regulate angiogenic process in favor of a quiescentphenotype (Phng and Gerhardt 2009). Fibroblasts make up the connective cells inthe advential layer of blood vessels, providing a connective tissue outer layer thatprovides structural stability (Gaengel et al. 2009). Mural cells also contribute to thestructural stability of blood vessels, allowing them to withstand the stresses ofsystemic blood flow and aiding in maintaining blood pressure (Gaengel et al. 2009).Association of advential cells is a key part of the blood vessel maturation process,with defects in advential layer development leading to leaky vessels and embryonicdeath (Gaengel et al. 2009).In addition to advential cells, the proteins comprising the ECM surroundingendothelial cells play a significant role in the development of vascular networks.
5
Networks of ECM deposited by endothelial cells and surrounding tissue cells containinactive isoforms of VEGF, which once activated by matrix metaloprotease-­‐dependent cleavage from the ECM trigger angiogenic growth of vascular networks(Akhta et al. 2001). Interaction with isolectins fibronectin and lamanin contributegreatly to vascular network formation (Risau and Lemmon 1988). Fibronectinincreases the proliferative and migratory potential of angioblasts while lamanindecreases the proliferative and migratory potential of angioblasts in favor ofpromoting angioblast differentiation into endothelial cells (Risau and Lemmon1988). Endothelial cell receptor interactions with integrin and immunoglobulincomponents of the surrounding ECM environment affect proliferation,differentiation, migration, activation, and gene expression (Baldwin 1996). Forinstance, the β1 integrin family plays a critical role in endothelial tube development,while α5 integrins have an earlier acting role in endothelial cell fusion to form afunctional early vessel network (Baldwin 1996; Drake et al. 1992; Yang et al. 1993).The Immunoglobulin-­‐like cell receptor molecule PECAM-­‐1 is expressed byendothelial cells throughout the vasculature and has a significant role in cell-­‐cellbinding interactions between vascular cells and non vascular cells that in theformation of a stable vascular network (DeLisser et al. 1994). ECM proteins andadvential cells provide a stable network for angioblast growth and differentiation.Without the signaling and structural support of advential cells and the ECM, theendothelial cells making up the structure of the preliminary blood vessel willregress to be incorporated into other stabilized blood vessels or commit apoptosis(Phng and Gerhardt 2009).
6
Many transcription factor families play a significant role in the formation ofvascular networks through developmental studies in vertebrate model systems.Among the earliest transcription factors to become activated in these processes arethe transcription factors Tal1 and Gata2 that distinguish the hemangioblast lineagefrom the mesodermal stem cells. Activation of Tal1 is sufficient to cause stem cells tocommit to an endothelial cell fate (De Val and Black 2009). Genetic analysis ofcommon endothelial cell genes also shows an abundance of Gata2 binding sites,suggesting that Gata2 is a key regulator of endothelial cell fate (De Val and Black2009). These transcription factors are controlled by the transcription factors Fli-­‐1and Etv2 (Brown et al. 2000, -­‐1). Among these early transcription factors are theFOX and ETS families of transcription factors that are key players in vasculogenicprocesses (De Val and Black 2009). Enhancer binding sites for these factors arefound among the promoter regions of several key genes in endothelial developmentincluding Tal1, Tie-­‐2, Flk-­‐1, and VE-­‐Cadherin (De Val and Black 2009). Many otherfactors are involved in the later processes of angiogenesis. For example, theaforementioned Notch signaling pathway limits angiogenic activity, seemingly tomaintain the order of the vascular network (Siekmann and Lawson 2007; Phng andGerhardt 2009).Commitment to arterial or venous fate seems to be determined by bothgenetic and environmental factors. Directional flow of blood plays a significant rolein determining arterial or venous fate. Ligation of arteries causes the vesselsdownstream of the ligation to shift from an arterial to venous fate in order to keepsystemic flow of blood undisturbed throughout the organism as a whole (le Noble et
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al. 2004). Genetically, several families of transcription factors are responsible forcommitment to arterial or venous fate. A reduction in Notch expression causes a lossof arterial blood vessels in addition to severe vascular developmental defects asdemonstrated by knockout models of Notch and Notch ligands, including Hey1 andHey2, in mice and knockdown models of Notch and Notch ligands in Zebrafish (Phngand Gerhardt 2009). Knockout of the FoxC family members FoxC1 and FoxC2 causesalmost complete absence of arterial markers in affected vasculature (Seo et al.2006). Sox7 and Sox18 null mice display severe vascular defects that includecomplete loss of tail and head circulation. Arterial development is also stunted as aresult of Sox7 and Sox 18 deletion in endothelial cells (Cermenati et al. 2008, 18).Conditional deletion of COUP-­‐TFII results in a shift from venous cell markers inveins to arterial markers (You et al. 2005). COUP-­‐TFII functions via suppression ofNotch activity, suggesting that arterial and venous identity is a balancing actregulated by relative amounts of Notch activity (Phng and Gerhardt 2009).
Murine coronary vessel developmentCoronary development occurs late in heart development. Briefly, the heartforms from the primary and secondary heart fields of the splanchic mesodermstarting around embryonic day 7.5 (e7.5) in the murine embryo (High and Epstein2008). Over the course of one day, the primary heart field forms the heart tube; acylindrical beating organ composed of an outer myocardial and an inner endocardiallayer. Over the next couple days, the heart undergoes the complex process oflooping and partitioning that specifies the two ventricles and two atria and thepreliminary outflow tract of the heart by e10.5 (High and Epstein 2008). By e14.5,
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the chambers of the heart are fully formed and most major morphological changesare completed with the exception of coronary vascular development (High andEpstein 2008).Coronary vascular development begins with the formation of the epithelialcell layer of the heart around e9.5 as an outgrowth from the proepicardial organ.The proepicardial organ originates from the coelomic mesothelium, whichcontributes to the epicardium of the heart as well as the endothelial cells liningmultiple tissues (Katz et al. 2012). Cells from the proepicardial organ attach to theatrioventricular region of the heart and proceed to migrate across the surface of theheart, forming the complete epicardial layer around e12.5 (Katz et al. 2012). Thesecells can be divided into different lineages based on cellular markers that denotetheir eventual fate. Proepicardial cells expressing Tbx18/WT-­‐1 become smoothmuscle cells while Sema3D positive cells become coronary endothelial cells (Katz etal. 2012). Coronary vascular progenitor cells are specified by epithelialmesenchymal transition (EMT) by e11 (Katz et al. 2012). Newly generatedmesenchymal cells migrate into the subepicardial space between the epicardial andmyocardial muscle layer of the heart, contributing to the coronary veins andcoronary arteries (Katz et al. 2012). Endothelial cells from the endocardium alsomigrate into the myocardium to contribute to the coronary vessel system (Wu et al.2012). Vascularization of the heart and vascularization of the embryo as a wholeshare many of the same signaling processes and events. As previously mentioned,coronary endothelial cells originate frommesenchymal tissues created by EMT of
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epithelial cells that make up the epicardium and frommigration of endothelial cellsfrom the endocardium (Wu et al. 2012; Pérez-­‐Pomares et al. 2002). Migration ofendothelial and mural cell progenitors of the coronary vessel system occurs inresponse to hypoxic signals frommyocardial cells. As the heart increases in mass,the process of diffusion cannot keep up with cellular demand for nutrient and wasteexchange. As a result, myocardial cells express signaling factors including HypoxicInduction Factor 1alpha (HIF-­‐1α) triggering the up regulation of FGF and VEGFsignaling in hypoxic regions (Tomanek et al. 2003; Yue and Tomanek 1999). VEGFsignaling stimulates the migration of coronary vessel progenitors from theepicardium and endocardium into the myocardium of the heart (Tomanek 2005; Wuet al. 2012). These progenitors co-­‐localize to form the initial coronary vascularplexus, first seen as blood islands interspersed throughout the myocardium andsubepicardial space (Wu et al. 2012; Tomanek 2005; Pérez-­‐Pomares et al. 1998).Blood islands, angioblasts, and advential cells come together as described above toform coronary blood vessels.Upon the establishment of the initial coronary vascular plexus, vesselnetworks expand towards the aortic lumen driven by angiogenic signalingmolecules (Tomanek et al. 2003; Tomanek 2005; Reese et al. 2002). Orifices termedcoronary ostia form in the aortic lumen through apoptosis of endothelial andsurrounding mural cells and the invasion of coronary vasculature (Tomanek 2005).The mechanisms that govern exact placement of the coronary ostia in the aorticlumen have not been fully described, however a combination of angiogenic signalinggradients and the specific curvature of the aorta at common regions of ostia
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formation play a key role in ostial placement (Turner and Navaratnam 1996; Eralp2005). These observations are further supported by the increase in coronary arteryanomalies in murine knockout models and in cases of outflow tract defects. Defectsin coronary artery formation include improper coronary artery placement, either inthe aortic lumen or in the pulmonary artery lumen (Angelini 2007). Normally, twocoronary ostia are present, providing origins for the three major coronary arteries:the left anterior descending artery, the right anterior descending artery, and theright circumflex artery (Tomanek 2005). The left anterior descending artery worksits way from the aorta down the left ventricle wall, while the right descending arterymakes its way down the right ventricle wall (Tomanek 2005). The right circumflexartery branches from the right anterior descending artery and works its way aroundto the posterior side of the heart. In the murine heart, the number and branchingpatterns of the coronary arteries are the main consistent features of coronaryvascular development (Reese et al. 2002).Coronary patterning anomalies restrict the blood flow to the heart byforming stunted and incomplete coronary vascular networks that do not allow forproper systemic flow of blood throughout the heart (Angelini 2007). Defects canmanifest as anomalous origin of the coronary arteries, classified as coronary ostialocations in areas seen in less than 1% of human patients and causing clearcirculatory defects (Angelini 2007). Anomalous origin of the coronaries can presentas ostia formation on the pulmonary artery, ostia formation on a single side of theaorta and or the formation of separate ostia for the right circumflex artery amongmany other possible origins. Intrinsic structural anomalies such as coronary vessel
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stenosis, (narrowing), ectasia (dialation), or atresia (under development or totalloss of a coronary vessel) can be observed in the coronary vasculature (Angelini2007). Defects in coronary vascular structure and origin may result from defectivevasculogenic and or angiogenic processes caused by defects at the cellular levelincluding migration, differentiation, proliferation, apoptosis, and defects in cell-­‐celladhesion. Fatal defects in coronary vascular development have been observed inmurine knockout models of key genes involved in each pathway. Defects inmigration caused by deletion of myocardial VEGF or endocardial VEGFR2a, result inembryonic lethality (Wu et al. 2012). Likewise deletion of GATA-­‐4 results in absenceof the epicardial layer of the heart. GATA-­‐4 null embryos do not develop coronaryvasculature, presumably due to the loss of coronary progenitor cells normallyprovided by the epicardium (Watt et al. 2004, -­‐4). Defective differentiation ofendothelial progenitors causes embryonic mortality of WT-­‐1 deficient embryos(Kreidberg et al. 1993). Ablation of VEGF and FGF signaling in postnatal rat heartsresults in defects in endothelial proliferation required for postnatal coronary vesselgrowth (Tomanek et al. 2001). Improper apoptotic signaling during coronary arteryformation contributes to a coronary vascular system unconnected to systemic bloodflow (Eralp 2005). Improper expression of VE-­‐Cadherin causes vascular fragility inzebrafish embryos when knocked down with morpholinos (Montero-­‐Balaguer et al.2009). Establishment of systemic circulation through the coronary vessel systemtriggers maturation processes that remodel the vasculature to ensure proper flowthroughout the coronary vessel systems. Vessels are stabilized by the incorporation
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of advential cells; smooth muscle cells, pericytes, and fibroblasts, generated fromthe epicardial mesenchyme that provide both mechanical stability to vessel wallsand promote differentiation and survival of endothelial cells (Tomanek 2005;Mikawa and Gourdie 1996). Advential cells migrate and differentiate into thecoronary vessel network through the PDGF, TGFβ signaling pathways as in themurine vasculature as a whole (Hirschi et al. 1998). Unstabilized vessels, vesselslacking advential cell associations, regress by endothelial cell dedifferentiation orapoptosis upon exposure to the hyperoxic conditions generated by establishment ofblood flow through the coronary vascular system (Tomanek 2005). Vessels arepruned in this manner postnatally in order to ensure proper communication ofblood through arterial and venous networks. Postnatal pruning ensures that bloodflow moves in one uniform direction by removing improper connections betweencoronary arterial and venous networks.
Chromatin dynamicsChromatin state is an often-­‐overlooked element in the regulation of proteinexpression. Chromatin is a mixture of DNA and organizational proteins that packagethe genetic information of the cell. The smallest unit of DNA packaging, thenucleosome, is composed of approximately 147 base pairs of DNA wrapped arounda histone octamer. Histone octamers are composed of two sets of the H2A, H2B, H3,and H4 histone subunits consisting of a globular structural domain and a linear taildomain that is largely structureless (Brownell and Allis 1996). Specific residues ofthe histone tail can play host to posttranslational modifications includingphosphorylation, methylation, and acetylation among others that cause changes in
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the chromatin structure leading to processes such as DNA replication ortranscription or repression of gene expression (Brownell and Allis 1996). Initially,these marks were believed to directly change the chemical interactions between thenet positive histone subunits and the net negative DNA backbone, a belief thatpersists to this day. Recent work however, suggests that these histone tailmodifications are more likely to alter chromatin composition through theassociation of protein complexes that physically unwind or otherwise shift thehistone core away from the DNA molecule (Flaus and Owen-­‐Hughes 2001). Once thehistone core has been displaced from a particular region, DNA replication ortranscription factors can associate and interact with the DNA template, replicatingDNA or transcribing an mRNA copy for translation or other processing events (Flausand Owen-­‐Hughes 2001). The proposed system of histone tail marking byposttranslational modifications creating binding sites for chromatin remodelingenzymes has lead to the distinction of two different types of remodeling enzymes;covalent histone remodeling enzymes that catalyze the posttranslationalmodifications and ATP-­‐dependent histone remodeling enzymes that unwind thenucleosome and displace the histone core in response to the posttranslationalmodifications present on histone cores.Covalent histone remodeling enzymes including phosphorylases, methylases,and acetyltransferases do not catalyze the unwinding of the nucleosome themselves;they mark histone tails to create a target-­‐binding site for active histone remodelingenzymes to form remodeling complexes (Gangaraju and Bartholomew 2007). Thesemarks can be transient or persistent depending on the region of DNA specified.
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Regions containing highly transcribed genes tend to have a significant number ofacetyl marks consistently present on their neighboring histone tails. Other, lessfrequently transcribed genes tend to only have transient acetyl marks onnucleosomes surrounding their promoter regions during times of gene expression(Brownell and Allis 1996). In general, acetylation and phosphorylation tend to leadto transcriptional activation and methylation tends to lead to transcriptionalrepression (Flaus and Owen-­‐Hughes 2001).The posttranslational state of a given histone tail is largely dependent uponthe interactions between enzymes that catalyze the addition of posttranslationalmodifications and enzymes that remove these posttranslational modifications. Assuch, phosphorylated histone tails can be dephosphorylated by phosphatases,acetylated histone tails can be deacetylated by deacetylases and methylated histonetails can be demethylated by demethylases. Generally, dephosphorylation anddeacetylation leads to transcriptional repression and demethylation leads totranscriptional activation (Flaus and Owen-­‐Hughes 2001). Transcription factorsmay also be posttranslationally modified to alter their activity. We have shownrecently that TBX5 is acetylated in murine cardiomyocyte progenitors, and thatdeacetylation of TBX5 is a key factor in proper cardiomyocyte differentiation inmurine heart development (Lewandowski et al. 2014). Among these modifications,acetylation is among the most common posttranslational modification regulatingtranscriptional activity, marking regions of transcriptionally active genes. Acetylmarks are deposited on lysine residues present on histone tails and other proteinsby acetyltransferases and are removed by lysine deacetylases.
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Posttranslational modifications lead to nucleosome re-­‐positioning, movingthe DNA molecule away from the histone core to generate enough space forreplication and or transcription to occur. Nucleosome unwinding is accomplished byATP-­‐dependent chromatin remodeling enzymes that use the chemical energy of ATPto catalyze the unwinding of the nucleosome or the removal of the histone core fromthe DNA molecule. ATP-­‐dependent chromatin remodeling enzymes are classified asmembers of four main families based upon homology and functionality; the INO80,SWI/SNF, Mi-­‐2 CHD and ISWI families (Bao and Shen 2007). These remodelingcomplexes all share an ATP-­‐hydrolyzing core that generates superhelical tension inthe DNA molecule, permitting local reconstruction of the DNA twist (Flaus andOwen-­‐Hughes 2001). Though there is some commonality in the ATP hydrolyzingdomain of ATP-­‐dependent chromatin remodeling enzymes, there are significantfunctional differences between each family of chromatin remodeling enzymes(Gangaraju and Bartholomew 2007). For example, ISWI requires a nucleosome withhistone tails to catalyze enzymatic reactions, while Mi-­‐2 does not require histonetails for reaction catalysis (Flaus and Owen-­‐Hughes 2001). The INO80 family of ATP-­‐dependent remodeling enzymes have a distinct insertion in the otherwise conservedATPase domain that may contribute to the INO80 family’s unique role in H2A.Zhistone variant localization, making the INO80 a key factor in double strand breakrepair and replication fork progression (Watanabe and Peterson 2010). Some ATP-­‐dependent remodelers have domains that allow them to interact with other DNAbinding proteins such as transcription factors and or bromodomains that couldinteract with modified histone tails, suggesting specific interaction with chromatin
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molecules at target regions based on protein binding and histone tail modifications(Flaus and Owen-­‐Hughes 2001). For instance, SWI/SNF is recruited to the HOgenomic region by the transcription factor Swi5p. SWI/SNF then catalyzesnucleosome structural changes that allow for the acetyltransferase SAGA toacetylate H3 and H4 lysine residues with the yeast HO genomic region (Cosma et al.1999; Krebs et al. 1999). As such, some ATP-­‐dependent remodeling complexes seemto play a vital role in modulating chromatin transcriptional accessibility. The specificorder of events varies depending on the specific genomic region. In some casesacetylation is required before any histone displacement occurs. In other cases,histone displacement is required for acetylation and subsequent transcription tooccur. Histone deacetylases (HDACs) fit into this process by removing and inhibitingthe acetylation of histone tails, shifting chromatin from an accessible euchromaticstate to a more repressive heterochromatin state through discouragement of ATP-­‐dependent remodeling complex association and binding, or discouragement ofenhancer and transcription factor binding.Transcriptional activation is balanced by the interplay between HATs andHDACs. HATs activate transcriptional activity by adding acetyl groups to lysineresidues present in histone tails, while HDACs catalyze the reverse reaction(Brownell and Allis 1996). Interestingly, HDACs and HATs frequently have the samebinding partners. A key example related to cardiac development is the MEF2transcription factor, which interacts with class II HDACs such as HDAC5 and HDAC9to suppress MEF2 activation of hypertrophic gene pathways. When HDAC5 orHDAC9 are knocked out using null alleles, cardiac response to hypertrophic stimuli
17
mediated by MEF2 is increased as a result (Chang et al. 2004). HDAC1 repressesNotch gene expression in Zebrafish neural development by competitive inhibition ofthe Notch intracellular domain binding to RBPJ (Cunliffe 2004). Thus, modulation ofchromatin state through the balanced interactions of HDACs and HATs plays asignificant role in the transcription of genes involved in many developmentalprocesses.
Histone DeacetylasesTo date, there are 18 HDACs that make up four different classes based onhomology to yeast deacetylase proteins and protein activity (Haberland et al.2009b). Classical HDACs make up HDAC class I, class II, and class IV, while non-­‐classical HDACs known as Sirtuins make up class III HDACs. Sirtuins differ fromclassical HDACs in that they require NAD+ for their catalytic activity (Michan andSinclair 2007). Classical HDACs are further broken down based on homology withyeast deacetylases. Ubiquitously expressed class I HDACs Consisting of HDAC1,HDAC2, HDAC3, and HDAC8 share homology with the yeast HDAC RPD3 (Haberlandet al. 2009b). Class I HDACs are commonly found in protein complexes such as theNURD CoREST complex for HDAC1 and HDAC2 and NCOR/SMRT complex forHDAC3 with the exception of HDAC8 (Haberland et al. 2009b). Class II HDACs aresplit into two subgroups: class IIa, made up of HDAC4, HDAC5, HDAC7, and HDAC9and class IIb, made up of HDAC6 and HDAC10. Class II HDACs are homologous toyeast HDAC Hda1 and differ from class I HDACs in several respects (Haberland et al.2009b). Class II HDACs as a whole have a more tissue-­‐specific expression pattern.Also, class II HDACs contain nuclear import and export signals, which allow them to
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localize to the nucleus and the cytosol depending on association with proteinchaperones such as 14-­‐3-­‐3 and MEF2 which localize class II HDACs to the cytoplasmand the nucleus respectively (Lahm et al. 2007). Class II HDACs also have decreasedHDAC activity due to a residue substitution in the catalytic active site of the HDACdomain that substitutes a tyrosine residue with a histidine residue, resulting in a1000-­‐fold decrease in protein activity (Lahm et al. 2007). HDAC6 and HDAC10 aremost homologous to one another. HDAC11 is the sole class IV HDAC. ThoughHDAC11 has been determined to have histone deacetylase activity, no biologicalfunction has been determined for this HDAC (Haberland et al. 2009b).
HDAC1 and HDAC2Hdac1 is critical in embryonic development. Deletion of Hdac1 in the murineembryo results in embryonic death prior to e10.5 as a result of proliferation defects.Observed proliferation defects are a result of increased expression of CDK inhibitorsp21 and p27, believed to be a response to increased global acetylation caused byloss of Hdac1 activity (Lagger et al. 2002, 1). Conditional deletion of the Hdac1 allelein the cardiac myocyte linage using a αMHC-­‐Cre driver did not result in aperceivable phenotype. Our prior studies suggest that deletion of Hdac2 results inpartial lethality due to increased cardiomyocyte hyperplasia. Surviving Hdac2-­‐nullmice displayed resistance to hypertrophic stimuli through the modulation of theGsk3β pathway (Trivedi et al. 2007). Hdac2 also interacts with Hopx to regulatecardiomyocyte proliferation by modulating Gata4 transcriptional activity (Trivedi etal. 2010).
HDAC3
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Murine embryos homozygous for an Hdac3-­‐null allele do not survive paste9.5 as a result of defects in gastrulation (Montgomery et al. 2008, 3). Defects ingastrulation may be a result of defects in S phase DNA repair, as seen in MouseEmbryonic Fibroblasts (MEFs) upon deletion of Hdac3 (Bhaskara et al. 2008).Cardiomyocyte-­‐specific deletion of Hdac3 results in metabolic defects incardiomyocytes, including lipid accumulation and defective utilization of glucose incardiomyocyte cells (Montgomery et al. 2008). Liver specific deletion of Hdac3causes a similar effect, with lipid accumulation in liver tissue leading to ahypertrophic growth response.13 Previously, we have shown that Hdac3 promotescardiomyocyte proliferation by repressing cyclin-­‐dependent kinase inhibitors(Trivedi et al. 2008). Recently, we have shown that Hdac3 deacetylates Tbx5 inorder to control differentiation of cardiomyocyte progenitor cells (Lewandowski etal. 2014). Hdac3 plays a significant role in endothelial cell progenitor celldifferentiation. Activation of Hdac3 is required in Sca1+ progenitor cells to produceendothelial cells (Xiao 2006). Shear stress induces Hdac3 activity in stem cellsthrough the Flk-­‐1-­‐PI3K-­‐Akt pathway, which leads to activation of p21 anddifferentiation into endothelial cells (Zeng et al. 2006, 3). Arterial injury wasreduced when endothelial cells differentiated from embryonic stem cells by Hdac3stimulation were introduced in injury models (Xiao 2006, -­‐1; Zeng et al. 2006).Hdac3 inhibits angiogenesis in tumor cells by reducing VEGF signaling and downregulating plasmogen activation inhibitor-­‐1 (PAI-­‐1) expression (Park et al. 2013).Isoforms of HDAC3 regulate endothelial mesenchymal transition through alteringHDAC3-­‐Akt activity (Zeng et al. 2013, 2). In addition, Hdac3 also deacetylates Mef2D,
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a transcription factor with known involvement in cardiac hypertrophy (Grégoire etal. 2007).
HDAC8HDAC8 is not associated with any known protein complexes unlike the otherthree members of the Class I HDAC family (Haberland et al. 2009b). Also, Hdac8does not cause cardiovascular defects upon deletion, suggesting that Hdac8 may notplay a major role in cardiovascular development. Hdac8 global deletion causesperinatal lethality in mice due to unstable skull development as a result of mis-­‐regulation of homeobox transcription factors (Haberland et al. 2009a).
Class IIa HDACsDeletion of Hdac4 in mice results in premature ossification of skeletal tissue.Resulting mutant mice die of asphyxiation due to inhibition of rib cage expansionrequired for proper breathing (Vega et al. 2004). Hdac4 inhibits the Runx2transcription factor, which promotes chondrocyte hypertrophy and differentiation.Over expression of Hdac4 in transgenic murine models has shown the inverse effect,resulting in mice with under ossified skeletons (Vega et al. 2004, 4). Deletion ofHdac5 and Hdac9 individually in murine models displays increased cardiachypertrophic phenotypes in response to hypertrophic stimuli (Zhang et al. 2002;Chang et al. 2004). Of further interest, simultaneous deletion of Hdac5 and Hdac9results in mice with ventricular septal defects and thin ventricle walls (Chang et al.2004). Hdac7 deletion in murine models causes embryonic lethality by e11,displaying vascular dilation in major arteries (Chang et al. 2006). Over-­‐expression ofMatrix Metaloprotease 10 (MMP10), an ECM degrading protein was linked to the
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observed vascular dilation phenotype. MEF2 activation of MMP10 is inhibited byinteractions with Hdac7, suggesting that Hdac7 plays a key role in vascular integrityby transcriptionally repressing the expression of MMP10 (Chang et al. 2006).
HDAC6Hdac6 is unique among the classical HDACs. Structurally, Hdac6 has twoHDAC domains; one functional and one unfunctional (Haberland et al. 2009b).Unlike the other HDACs, which are active mainly in the nucleus, observed Hdac6activity occurs in the cytoplasm in association with microtubule proteins (Hubbertet al. 2002). As such, Hdac6 is a microtubule deacetylase. However, Hdac6 associateswith ubiquitination machinery suggesting a role in protein turnover (Sadoul et al.2008). Deletion of Hdac6 causes hyperacetylation of skeletal microtubules in micebut does not result in lethality (Hubbert et al. 2002, 6).
Class III HDACsClass III HDACs are made up of the NAD+ dependent Sirtuin family that sharehomology with yeast HDAC Sir2 (Rajendran et al. 2011). The Sirtuin family ofHDACs comprises seven members, each sharing a common deacetylase domain, butdifferentiated by unique N and C terminal sequences (Michan and Sinclair 2007).Sirtuins deacetylate their targets by a two-­‐step mechanism in which NAD+ ishydrolyzed to nicotinamide, leading to the generation of an acetyl-­‐ADP-­‐ribosemetabolite (Landry et al. 2000; Michan and Sinclair 2007). Sirtuins are also distinctin their sub-­‐cellular localization, with Sirt1 Sirt6 and Sirt7 predominantly localizedin the nucleus associated with euchromatin, heterochromatin, and the nucleolusrespectively (Michan and Sinclair 2007). Sirt2 is the predominant cytoplasmic
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Sirtuin while Sirt3, Sirt4, and Sirt5 localize to the mitochondria (Michan and Sinclair2007). Sirt1 plays a role in the formation of heterochromatin, and gene expression,targeting lysine residues in H3 and H4 histone tails (Michan and Sinclair 2007;Vaquero et al. 2004). Sirt7 is an activator of RNA-­‐Pol I-­‐mediated transcriptionthrough interaction with RNA Pol I machinery and the expression of ribosomal RNAgenes (Michan and Sinclair 2007). Sirtuins have been shown to interact withtranscription factors such as MyoD and Mef2 in order to modulate muscle celldifferentiation and proliferation (Michan and Sinclair 2007; Fulco et al. 2003; Zhaoet al. 2005). Sirt1 interacts with CDK pathway gene p53 and the FOXO transcriptionfactor family, as a potential means to regulate cell proliferation and differentiationin response to metabolic and apoptotic signaling (Chen et al. 2005; Nakae et al.2006). In respect to cardiovascular development, Sirt1 protects cardiomyocytesfrom apoptosis in a p53 dependent manner upon serum starvation or DNA damage(Kolthur-­‐Seetharam et al. 2006; Pillai et al. 2014, 2005). Sirt1 also promotes thedegradation of the H2A.Z histone variant known to promote cardiac hypertrophy(Chen et al. 2006). Sirt3, Sirt6, and Sirt7 act in addition to Sirt1 to inhibit cardiachypertrophy. Sirt7 also deacetylates p53 to inhibit cardiomyocyte apoptosis andinhibit cardiac hypertrophy (Vakhrusheva et al. 2008, 7). Sirt3 represses cardiachypertrophy by inhibition of Akt signaling and by activating FoxO3a antioxidantsignaling pathways (Sundaresan et al. 2009, 3; Sebastian et al. 2012). Sirt6 repressesAkt signaling by repressing NF-­‐κB and cJun transcriptional activity (Sundaresan etal. 2012, 6; Yu et al. 2013, 6). In the vascular system, Sirt1 plays a critical role in
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tissue revascularization after ischemic injury (Potente et al. 2007; Oellerich andPotente 2012). Sirt1 counteracts the anti-­‐angiogenic signaling of FOXO1 throughdeacetylation of the FOXO1 protein (Potente et al. 2007). In addition todevelopmental roles, Sirt1 plays a significant role in the physiological relaxation ofcerebral blood vessels by regulating the endothelium dependent reaction to NOsignaling (Tajbakhsh and Sokoya 2012). NO regulation may be the result of Sirt1-­‐dependent activation of eNOS in response to increased flow (Chen et al. 2010). Theability of Sirt1 to deacetylate eNOS leads to identification of Sirt1 as a key factor inmaintaining vascular health and responsiveness and reducing the effects of aging onvascular systems (Oellerich and Potente 2012). Sirt1 also regulates endothelialgrowth by degrading PHD2, an inhibitor of HIF-­‐2α and activating HIF-­‐2α throughdeacetylation dependent processes (Rane et al. 2009; Dioum et al. 2009).
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Chapter II
Endothelial specific deletion of HDAC3 in mice results in aberrant coronary
vasculature and postnatal lethality
25
Rationale and SignificanceHdac3 functions as a key epigenetic regulator of differentiation andproliferation processes essential to the development of the cardiovascular system(Haberland et al. 2009b; Bhaskara et al. 2008, 3). However, the role of Hdac3 in theendothelial cells of the developing embryo has not been examined in vivo.Conditional Hdac3 mice provide an opportunity to study Hdac3 in vasculardevelopment, providing some much-­‐needed elucidation of the role of this Hdac inmammalian developmental processes.
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Results
Deletion of Hdac3 in endothelial cells results in Postnatal LethalityTo determine the role of Hdac3 in endothelial cell during development, wedeleted Hdac3 using endothelial cell specific Cdh5-­‐driven Cre recombinase (termedas Hdac3EKO). Hdac3EKO pups were recovered at postnatal day 0 (p0) in near-­‐Mendelian ratios (Table 1). Hdac3EKO pups were not observed beyond p14 (Table 1).
Loss of Hdac3 results in coronary vessel defectsGross analysis of the peripheral vessels of Hdac3EKO embryos appearednormal at e14.5 and e16.5 (Figure 1, 2). We began evaluating the phenotype ofHdac3EKO pups by dissecting out the hearts at p0, p6 and p7. Three wild type(Hdac3F/F, or Hdac3+/+) and three knockout hearts were examined at each timepoint. AllHdac3EKO hearts displayed aberrant coronary vessels (Figure 3-­‐5).Hdac3EKO embryos display occasional ventricular septal defectsThe Endocardium plays a significant role in heart development, contributingto valvular and septal development in addition to coronary vessel development (Linet al. 2012). The tricuspid and mitral valve appeared normal (Figure 6). Hdac3EKOembryos displayed occasional ventricular septal defect (Figure 7).
Methods
Generation of Hdac3EKOmice.The Hdac3 floxed allele mouse and the VE Cadhernin Cre (Cdh5 Cre) mousehave been previously described (Mullican et al. 2011; Alva et al. 2006). Breedingsbetween hdac3flox/+ mice and hdac3flox/+; cdh5 cremice were established and pupswere collected at p0 and p14 for survival tables. Survival of hdac3flox/flox; cdh5 cre
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(Hdac3EKO) was measured against expected Mendelian ratios by Chi square analysis.Significance was verified using Student’s Two-­‐tailed T test. Embryos and pupscollected for histology were the result of breedings between either hdac3flox/+ miceand hdac3flox/+; cdh5 cre or hdac3flox/flox and hdac3flox/+; cdh5-­cremice. Approximateage of collected embryos was determined by observation of vaginal plug by probe.The date of the observed plug was marked as e0.5. At the appropriate embryonicday, pregnant mothers were euthanized as per animal protocol. Pups wereharvested at postnatal day 0 (p0), p6 and p7 as determined by date of birth, markedas p0. Embryos and pups were genotyped using PCR amplification of Hdac3 andCdh5 Cre genomic DNA. PCR products of amplifications were run on agarose gelswith known controls. The University of Massachusetts Medical School InstitutionalAnimal Care and Use Committee approved all animal protocols.
Histological analysis of embryos and postnatal pup heartsEmbryos and hearts where photographed upon harvesting with a dissectionmicroscope. Once harvested, embryos and hearts were fixed overnight in 2% PFA.Tissues were dehydrated using a graded series of ethanol washes. Embryos andhearts were stored in 100% ethanol at -­‐20OC. Hearts and embryos were embeddedin Paraffin and 6-­‐8 micron sections were cut with a microtome and adhered to glassmicroscope slides. Slides were dried overnight and stored at 4OC until use. Everythird or fourth slide was stained with Hemotoxylin and Eosin.
Immunostaining:Deletion of Hdac3 was verified by HRP staining for Hdac3 on adjacent slides.Sections were washed with xylenes for three minutes a total of three times. Slides
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were rehydrated through washes in a graded ethanol series (100%, 95%, 70%,50%) slides were washed in distilled water for five minutes, then washed in PBS for10 minutes. Antigen retrieval was conducted in 10mM Sodium Citrate buffer(pH6.0) for 10 minutes at 95OC. Slides were cooled to room temperature andincubated in blocking buffer consisting of 1% horse serum 1% BSA and 0.3% TritonX100 for one hour at room temperature. Slides were washed with PBS for fiveminutes a total of three times. Hdac3 primary antibody (Santa Cruz sc-­‐11417) wasdiluted in PBS containing 2.5% horse serum to a final dilution of 1:200. Slides wereincubated with primary antibody for one hour at room temperature. Slides werewashed in PBS as detailed above. Next, slides were incubated with a universalbiotinylated secondary antibody (Vectastain ABC kit, Vector) for one hour at roomtemperature. PBS washes were conducted as detailed above. Then, slides wereincubated with Vectastain ABC reagent (Vector) for one hour at room temperature.Slides were washed in PBS as above. Development was conducted using a DABsubstrate kit as per manufacturer’s instructions (Vector). Slides were dipped in ice-­‐cold distilled water and washed in tap water for five minutes. Slides weredehydrated through a graded ethanol series (30%, 50%, 70%, 95%, 100%) andwashed three times for five minutes with Xylenes. Slides were mounted withVectaMount Permanent mounting medium (Vector). Brightfield microscope imagesof stained slides were taken and tissues were compared on similar levels.
DiscussionCoronary vascular anomalies make up approximately 33% of cardiovascularanomalies that result in sudden death (Angelini 2007). These anomalies are often
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known as the “silent killers” of the cardiovascular anomaly world, displaying noovert symptoms in a majority of cases with most being diagnosed when othercardiovascular problems arise or post-­‐mortem (Hauser 2005). We have shown thatdeletion of endothelial Hdac3 results in post-­‐natal lethality in mice by generation ofcoronary vessel defects. The observed phenotype of post-­‐natal death caused bycoronary vessel defect is novel to the mouse model system. Prior study of coronarydefects using mouse models has resulted in embryonic lethality (Wu et al. 2012;Mellgren et al. 2008; Singh et al. 2011; Zhou et al. 2009, -­‐2). Thus, work with Hdac3may lead toward the establishment of the first model system for coronary vesselinduced postnatal lethality.Observed coronary defects are similar to defects seen with in previouslydescribed knockout models. Deletion of Vegf in the myocardium or Vegfr2a in theendocardium results in hemorrhaging and loss of coronary vessel surface areacoverage (Wu et al. 2012). Sox18 and Sox7 deficiency mouse model causes ahemorrhagic phenotype with stunted coronary vessel growth (Downes andKoopman 2001; Cermenati et al. 2008). These phenotypes are similar to theobserved phenotypes in our knockout Hdac3 mice (Figure 5), albeit at earlier timepoints. Thus, Hdac3 may be a crucial regulator of transcription factor activity duringpostnatal coronary vessel growth.Our findings dovetail into recent work showing that the endocardiumcontributes endothelial cells to the coronary vessel system. Fate mapping studiesusing the Endocardial specific Nfatc1 Cre mark approximately 80% of coronaryartery endothelial cells with trace contributions to coronary veins (Wu et al. 2012).
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As such, Hdac3 may play a role in the migration of endothelial cells from theEndocardial layer of the heart into the myocardium and subepicardium wherecoronary vessels form. Further experimentation will be required to determine themolecular role of Hdac3 in coronary vessel development.The role of epigenetic factors in cardiac development continues to beadvanced. Here we have begun to unravel the contributions of Hdacs in coronaryvascular development. Future work will determine the molecular basis of Hdac3activity in coronary vessel development. Prior work has demonstrated a role forHdac3 in negative regulation of angiogenic process (Park et al. 2013). In addition,we have shown Hdac3 involvement in cardiomyocyte differentiation, while othershave shown a requirement for Hdac3 in differentiation of stem cells and vascularprogenitor cells (Lewandowski et al. 2014; Xiao 2006, 1; Zeng et al. 2006, 3). ThusHdac3 may play a key role in regulating endothelial cell dedifferentiation towards amigratory progenitor cell state for incorporation into the coronary vessel system.
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Figures
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Figure 1: Gross observation and histological analysis of E14.5 embryos.
Embryo pictures were taken in PBS post-­dissection at approximately 0.8X.
Sections were stained with Hematoxalin and Eosin. RA = right atria, LA = left
atria, RV = right ventricle, LV = left ventricle. Arrows denote coronary vessels.
Scale bar = 50 μM
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Figure 2: Gross observation and histological analysis of E16.5 embryos.
Embryo pictures were taken in PBS post-­dissection at approximately 0.8X.
Sections were stained with Hematoxalin and Eosin. RA = right atria, LA = left
atria, RV = right ventricle, LV = left ventricle, CA = coronary artery, CV=
coronary vein. Scale bar = 50 μM.
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Figure 3: Gross observation and histological analysis of P0 hearts. Heart
pictures were taken in 100% ethanol post-­dissection at approximately 2.5X.
Sections were stained with Hematoxalin and Eosin. RA = right atria, LA = left
atria, RV = right ventricle, LV = left ventricle, CA = coronary artery CV =
coronary vein. Arrows denote coronary vessels. Scale bar = 50 μM
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Figure 4: Gross observation and histological analysis of P6 hearts. Heart
pictures were taken in 100% ethanol post-­dissection at approximately 2.5X.
Sections were stained with Hematoxalin and Eosin. RA = right atria, LA = left
atria, RV = right ventricle, LV = left ventricle, CA = coronary artery CV =
coronary vein. Arrows denote coronary vessels. Scale bar = 50 μM. Arrows
denote observed hemorrhaging.
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Figure 5: Gross observation and histological analysis of P7 hearts. Heart
pictures were taken in 100% ethanol post-­dissection at approximately 2.5X.
Sections were stained with Hematoxalin and Eosin. RA = right atria, LA = left
atria, RV = right ventricle, LV = left ventricle, CA = coronary artery CV =
coronary vein. Arrows denote coronary vessels. Scale bar = 50 μM. Arrows
denote observed hemorrhaging Arrowheads denote endocardial endothelial
cell nuclei.
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Figure 6: Mitral and Tricuspid valves of HDAC3EKO mice. Hearts were dissected
out of p0 pups, sectioned and stained with Hemotoxylin and Eosin. Top panels
are taken at 2X magnification while lower panels are taken at 10X
magnification. RA = right atria, LA = left atria, RV = right ventricle, LV = left
ventricle, TV = tricuspid valve, MV =mitral valve.
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Figure 7: Ventricular septal defects observed in Hdac3EKOmice. E14.5 embryos
were sectioned and stained with H & E. Deletion of HDAC3 was confirmed with
HDAC3 HRP staining. Arrowhead denotes malformation in the ventricular
septum. Arrows denote endocardial endothelial cells
39
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